Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Geovax Labs (GOVX)

Geovax Labs (GOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
New Vaccine Technologies Lead the Charge as Global Immunization Efforts Evolve BayStreet.ca - Wed Dec 18, 8:34AM CST

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...

PCVX : 87.08 (+0.64%)
BVAXF : 0.0489 (+2.95%)
BIOV.CN : 0.0650 (unch)
GILD : 93.40 (+0.90%)
GOVX : 2.21 (-3.49%)
ARCT : 16.51 (+6.65%)
GeoVax Labs, Inc. Secures U.S. Patent Notice of Allowance for Tumor Immunotherapy Technology Quiver Quantitative, Inc. - Mon Dec 9, 6:26PM CST

GeoVax Labs receives patent allowance, enhancing its intellectual property for cancer immunotherapy using its unique viral vector platform.Quiver AI SummaryGeoVax Labs, Inc. announced that the U.S. Patent...

GOVX : 2.21 (-3.49%)
Author
3 Penny Stocks Ready to Break Out in 2025 MarketBeat - Fri Nov 29, 7:00AM CST

Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.

VUZI : 4.50 (+2.27%)
CRDL : 1.2500 (-2.34%)
GOVX : 2.21 (-3.49%)
GeoVax Labs, Inc. CEO David Dodd to Present at NobleCon20 Conference Quiver Quantitative, Inc. - Tue Nov 26, 6:24PM CST

GeoVax Labs announces CEO David Dodd will present at NobleCon20 on corporate updates and clinical trials.Quiver AI SummaryGeoVax Labs, Inc., a biotechnology company focused on human vaccines and cancer...

GOVX : 2.21 (-3.49%)
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks Stocktwits - Fri Nov 22, 2:10PM CST

Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.

SIGA : 5.94 (+0.51%)
EBS : 8.15 (+0.62%)
GOVX : 2.21 (-3.49%)
CMRX : 3.02 (+1.00%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth FinancialNewsMedia - Thu Jun 20, 9:00AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END

ONCY : 0.9058 (+9.00%)
ONC.TO : 1.29 (+8.40%)
GOVX : 2.21 (-3.49%)
GSK : 34.06 (+1.37%)
AZN : 66.63 (+1.96%)
MRK : 99.37 (+1.35%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth GlobeNewswire - Thu Jun 20, 9:00AM CDT

ONCY : 0.9058 (+9.00%)
ONC.TO : 1.29 (+8.40%)
GOVX : 2.21 (-3.49%)
GSK : 34.06 (+1.37%)
AZN : 66.63 (+1.96%)
MRK : 99.37 (+1.35%)
GeoVax Reports 2022 Second Quarter Financial Results and Provides Corporate Update Globe Newswire - Wed Aug 3, 2022

Advancing Phase 2 Clinical Trials for COVID-19 and Immuno-Oncology Evaluation of Company’s Vaccine Platform Against Monkeypox Underway ATLANTA, GA,...

GOVX : 2.21 (-3.49%)
GOVXW : 0.1240 (-0.40%)
GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Sudan Ebolavirus Showing 100% Protection With a Single Immunization Globe Newswire - Thu Jul 28, 2022

ATLANTA, GA, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human vaccines and...

GOVXW : 0.1240 (-0.40%)
GOVX : 2.21 (-3.49%)
GeoVax to Report Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 and Provide Corporate Update Globe Newswire - Tue Jul 26, 2022

Conference Call to be Held Wednesday, August 3, at 4:30 p.m. Eastern Time ATLANTA, GA, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs,...

GOVXW : 0.1240 (-0.40%)
GOVX : 2.21 (-3.49%)

Barchart Exclusives

Why This Dividend Stock Just Scored a Rare Upgrade Barchart - Mon Dec 23, 6:30PM CST
Bristol Myers Squibb, a global biopharma company, has received a rare upgrade from Jefferies due to its promising pipeline and strategic partnerships. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot